Clinical Trial: ALLIANCE A052101

ALLIANCE A052101

Status: Open

A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma (INTERCON)

Eligible for screening study DCP 001